Health Care/Hospital

Bill and Melinda Gates call for collaboration, continued innovation to overcome challenges of delivering COVID-19 scientific breakthroughs to the world

Gates Foundation pledges additional $250 million to accelerate development and equitable distribution of COVID-19 tests, treatments, and vaccines to end the pandemic SEATTLE, Dec. 10, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced it will commit an additional$250 millio...

2020-12-10 13:01 1889

Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Consortium (PNOC) for New Paxalisib Combination Study in DIPG

SYDNEY, Dec. 10, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clinical trial of...

2020-12-10 12:51 6134

Beijing Forum 2020 shines a spotlight on new challenges and opportunities of globalization

BEIJING, Dec. 10, 2020 /PRNewswire/ -- The Beijing Forum 2020 opened at Peking University onDecember 5, with bilingual live broadcasts across multiple platforms. This year, the international academic event, co-organized by Peking University, Beijing Municipal Education Commission, and Chey Instit...

2020-12-10 12:26 3352

Stellar Results from Kintor's GT90001 and Opdivo Combo Therapy in the Second-line Treatment of Advanced Liver Cancer: ORR Reached up to 40%

SHANGHAI, Dec. 10, 2020 /PRNewswire/ -- On December 9, 2020, Kintor Pharmaceutical Limited (HKEx: 9939) is pleased to announce that the Group has collected positive data in phase II clinical trials of combination therapy of ALK-1 (GT90001) antibody and PD-1 (Nivolumab or Opdivo) antibody for the ...

2020-12-10 12:14 2352

Cybernet on the Front Lines of Massive Vaccination Program

IRVINE, Calif., Dec. 10, 2020 /PRNewswire/ -- All eyes are on the United Kingdom today as they are the first western country in the world to begin to issue COVID-19 vaccinations. This ambitious undertaking, which has been dubbed the largest mass-vaccination program in the country's history, will ...

2020-12-10 10:43 1665

Sports Taping by 3NS, a Korean Kinesiology Tape Producer, Landing in Germany

BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- It is easy to see athletes taping their knees, thighs, ankles, and arms in various sports events such as marathon and basketball. The Kinesiology Tape has made steady progress since 1970 with the aim of preventing injuries and muscle pain to athletes...

2020-12-10 09:37 1156

3NS, a Korean Kinesiology Tape manufacturer, recommends effective use of sports tape

BERLIN, Germany, Dec. 10, 2020 /PRNewswire/ -- Kinesiology Tape, a sports product and medical device that can prevent injuries and relieve pain with simple use, is drawing attention these days when home training is happening more often during this Pandemic. The Kinesiology Tape, a flexible sport...

2020-12-10 09:36 1171

Ascentage Pharma Announces Updates on the Clinical Development of APG-2575, including an ORR of 70% in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia

SUZHOU, China and ROCKVILLE, MD, Dec. 10, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced updates on the clinical devel...

2020-12-10 09:03 1859

CStone's Partner Blueprint Medicines Announces U.S. FDA Approval of GAVRETO (pralsetinib) for the Treatment of Patients with Advanced or Metastatic RET-Mutant and RET Fusion-Positive Thyroid Cancer

SUZHOU, China, Dec. 10, 2020 /PRNewswire/ -- The partner of CStone Pharmaceuticals ("CStone", HKEX: 2616), Blueprint Medicines, announced on December 1st that the U.S. Food and Drug Administration (FDA) has approved GAVRETO™ (pralsetinib) for the treatment of patients with RET-altered thyroid can...

2020-12-10 08:30 3571

New Global Pooled Analysis Supports Clinical Utility of Circulating Tumor Cell Count for Early Monitoring of Metastatic Breast Cancer

Robust pooled analysis demonstrating how CTC count may help to optimize treatment choices BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire/ -- Menarini Silicon Biosystems , a pioneer of liquid biopsy technology, todayannounced

2020-12-10 01:59 2153

RxPONDER Study Results Demonstrate that the Oncotype DX® Test Can Now Spare Chemotherapy Use in the Majority of Women with Node-positive Early-stage Breast Cancer

- First results from the independent SWOG Cancer Research Network-led Phase III study to be presented at the 2020 San Antonio Breast Cancer Symposium - RxPONDER results from over 5,000 women likely to transform the treatment of node-positive breast cancer, as the TAILORx study did in node-negativ...

2020-12-09 22:00 2759

Sirtex Medical announces strategic investment in BlackSwan Vascular, Inc.

WOBURN, Mass., Dec. 9, 2020 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, announced a strategic investment in BlackSwan Vascular, Inc. (BlackSwan), a Bay Area-based private company developing groundbreaking therapies in endovascular emboliza...

2020-12-09 22:00 1285

Northway Biotechpharma, Biologics CDMO, Announces Company Brand Name Change to Northway Biotech

VILNIUS, Lithuania and WALTHAM, Mass., Dec. 9, 2020 /PRNewswire/ -- Northway Biotechpharma, providing end-to-end contract drug development and manufacturing (CDMO) services, announces brand name change toNorthway Biotech. Along with the tradename change, Dr. Vladas Algirdas Bumelis also returns t...

2020-12-09 21:39 1282

INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of Precancerous Anal Dysplasia Caused by HPV-16/18

PLYMOUTH MEETING, Pa., Dec. 9, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer and diseases associated with HPV, today announced positive Phase 2 efficacy ...

2020-12-09 21:00 3569

MiCAN Technologies' myeloid lineage cells help researchers fight COVID-19

KYOTO, Japan, Dec. 9, 2020 /PRNewswire/ -- MiCAN Technologies , a research service provider based in Kyoto Japan, revealed today that its human myeloid lineage cells[1] have been used to conduct research on the coronavirus SARS-CoV-2, which is responsible for ...

2020-12-09 20:49 1452

Bangkok Smile Dental Clinic SUKHUMVIT 5 Achieves GHA's COVID-19 Certification of Conformance for Medical Travel

WEST PALM BEACH, Fla., Dec. 9, 2020 /PRNewswire/ -- Bangkok Smile Dental Clinic SUKHUMVIT 5 (https://www.bangkoksmiledental.com/), a renowned dental clinic located inBangkok, Thailand, was awarded Global Healthcare Accreditation's Certification of Conformance with COVID-19 Guidelines for Medical ...

2020-12-09 19:00 2347

Global Korea Convention opens to spotlight Seoul's achievements in int'l cooperation

SEOUL, South Korea, Dec. 9, 2020 /PRNewswire/ -- An international forum kicked off inSeoul on Wednesday to share South Korea's achievements in global cooperation and explore its future roles and challenges in the post-COVID-19 era. The National Research Council for Economics, Humanities and Socia...

2020-12-09 18:22 3748

HBM Holdings Limited Announces the Offer Price and Allotment Results of the Global Offering

This press release is NOT for release, publication, distribution, directly or indirectly, in or intothe United States (including its territories and possessions, any state ofthe United States and the District of Columbia) or any other jurisdiction where such distribution is prohibited by law. Thi...

2020-12-09 17:29 5913

Generali launches a market-first Bill Insurance to address customers' needs with innovative solutions

HONG KONG, Dec. 9, 2020 /PRNewswire/ -- Generali Hong Kong today announced the launch of a market-firstBill Insurance – an innovative solution created to cover the utility bills of an individual by paying a lump sum benefit in the event the insured is hospitalised for more than 3 consecutive days...

2020-12-09 12:00 3007

Innovative B2B medical platform Medwish gears up for global Makeshift hospitals

HONG KONG, Dec. 9, 2020 /PRNewswire/ -- Hong Kong' first makeshift hospital at the Asia World-Expo, started operations onAug 1, and had partnered with Medwish.com as keysupplier. Medwish is an innovative B2B medical platform dedicated to empowering hospitals worldwide via offering order financing...

2020-12-09 10:12 1688
1 ... 393394395396397398399 ... 555